Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Myasthenia gravis

Journal article

Gilhus NE. et al, (2019), Nature Reviews Disease Primers, 5

Antiglycine receptor antibody related disease: a case series and literature review.

Journal article

Swayne A. et al, (2018), Eur J Neurol, 25, 1290 - 1298

NMDA-receptor antibodies alter cortical microcircuit dynamics.

Journal article

Rosch RE. et al, (2018), Proceedings of the National Academy of Sciences of the United States of America, 115, E9916 - E9925

Passive Transfer of Human CASPR2 Antibodies into Mice Causes Behavioral and Neuropathological Changes

Conference paper

Giannoccaro MP. et al, (2018), ANNALS OF NEUROLOGY, 84, S137 - S137

SHP2 INHIBITION BY NSC-87877 RECOVERS THE PATHOGENIC IN VITRO EFFECTS OF MUSK-MG ANTIBODY SUBCLASSES

Conference paper

Cao M. et al, (2018), MUSCLE & NERVE, 58, S15 - S16

A passive transfer animal model of CASPR2 antibodies

Conference paper

Giannoccaro MP. et al, (2018), EUROPEAN JOURNAL OF NEUROLOGY, 25, 674 - 674

Brain-relevant antibodies in first-episode psychosis: a matched case-control study.

Journal article

Gaughran F. et al, (2018), Psychol Med, 48, 1257 - 1263

Pathogenic Mechanisms and Clinical Correlations in Autoimmune Myasthenic Syndromes.

Journal article

Cetin H. and Vincent A., (2018), Semin Neurol, 38, 344 - 354

Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody.

Journal article

Hacohen Y. et al, (2018), Multiple sclerosis (Houndmills, Basingstoke, England), 24, 679 - 684

Serological and experimental studies in different forms of myasthenia gravis (vol 1413, pg 143, 2018)

Journal article

Vincent A. et al, (2018), ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1417, 130 - 130

Load More